Legend Biotech (LEGN) Receivables - Net (2019 - 2026)
Legend Biotech (LEGN) reported Receivables - Net of $1.7 million for Q1 2026, up 360.7% from $369,000 a year earlier but down 87.0% from the prior quarter.
Powered by 
Analysis
Legend Biotech (LEGN) Receivables - Net (2019 - 2026) Analysis & Trends
At the end of FY2025, Legend Biotech posted Receivables - Net of $13.1 million, up 104.7% from FY2024.
- Receivables - Net has a five-year compound annual growth rate of -29.5% (FY2020 to FY2025).
- By year, Receivables - Net came in at $6.4 million in FY2024 (-93.6%), $100.04 million in FY2023, $90,000 in FY2022 (-99.8%) and $50.41 million in FY2021 (-32.8%).
- Five-year quarterly Receivables - Net spans a low of $20,000 in Q3 2023 and a high of $100.04 million in Q4 2023.
- Year over year, Receivables - Net has now increased in each of the last four quarters, with growth averaging 65.2% over the last seven quarters.
- The high point for year-over-year Receivables - Net in five years was Q1 2026 (growth of 360.7%); the low point was Q1 2023 (a decline of 99.9%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $13.1 million (Q4 2025), $1.24 million (Q3 2025) and $27.58 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Legend Biotech | 3.43 Bn | -308.34 Mn | 251.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | 13.10 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 27.58 Mn |
| Mar 31, 2025 | 369,000.00 |
| Dec 31, 2024 | 6.40 Mn |
| Sep 30, 2024 | 705,000.00 |
| Jun 30, 2024 | 13.06 Mn |
| Mar 31, 2024 | 3.31 Mn |
| Dec 31, 2023 | 100.04 Mn |
| Sep 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 15.06 Mn |
| Mar 31, 2023 | 56,000.00 |
| Dec 31, 2022 | 90,000.00 |
| Mar 31, 2022 | 50.45 Mn |
| Dec 31, 2021 | 50.41 Mn |
| Sep 30, 2021 | 1.50 Mn |
| Jun 30, 2021 | 15.00 Mn |
| Dec 31, 2020 | 75.00 Mn |
| Dec 31, 2019 | 29.99 Mn |
API Access
Legend Biotech Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=LEGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "LEGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=LEGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();